Sergio Thal, MD
- Director of Lead Management Program, Electrophysiology, UH Cleveland Medical Center
- Associate Program Director, Electrophysiology, UH Cleveland Medical Center
- Clinical Associate Professor, CWRU School of Medicine
- Specialty: Cardiology, Cardiology-Clinical Cardiac Electrophysiology
-
Location:UH Ahuja Medical Center
3999 Richmond Rd
Beachwood, OH 44122
- Call: 216-593-1308
Biography: Sergio Thal, MD
Expertise
Certifications & Memberships
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Clinical Cardiac Electrophysiology
Clinical Cardiac Electrophysiology - Cleveland Clinic (2004 - 2006)
Medical Education
Universidad De Buenos Aires, Facultad De Ciencias Medicas (1993)
About
Sergio Thal, MD, is a clinical cardiac electrophysiologist and directs the Lead Management Program at University Hospitals Harrington Heart & Vascular Institute. He is also a Clinical Associate Professor at Case Western Reserve University School of Medicine.
Dr. Thal earned his medical degree from the University of Buenos Aires in Argentina. His postdoctoral training included residencies in internal medicine and cardiology, followed by a fellowship in cardiology, where he was named chief fellow, at Sanatorio Julio Mendez Hospital in Buenos Aires. He later completed a fellowship in clinical cardiac electrophysiology at the Cleveland Clinic in Cleveland, Ohio.
Dr. Thal is board certified in cardiovascular disease and clinical cardiac electrophysiology. His special areas of expertise include the diagnosis and treatment of patients with atrial fibrillation and ventricular tachycardia, as well as cardiac device implants such as pacemakers, cardiac defibrillators, biventricular pacing devices and lead extractions.
In addition to his clinical practice, Dr. Thal has authored clinical publications and presents at national professional meetings on topics related to therapeutic innovations and optimal care for patients with heart arrhythmias. He is also a member of distinguished organizations including the Argentine Society of Cardiology and Heart Rhythm Society.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sergio Thal did not disclose any Outside Relationships with Industry.